Updated Clinical Data from Several AeroForm Studies on Breast Cancer At The ASPS Annual Meeting 2014

Updated Clinical Data from Several AeroForm Studies on Breast Cancer At The ASPS Annual Meeting 2014
AirXpandersThe latest data from AirXpanders Inc.'s clinical study of its new expansion system for mastectomy patients undergoing breast reconstruction, AeroForm, were presented at Plastic Surgery The Meeting, the annual scientific meeting of the American Society of Plastic Surgeons (ASPS). The AeroForm tissue expander is a patient controlled breast tissue expander that comes equipped with a small handheld wireless controller that administers small amounts of CO2 into the device, stretching the skin to accommodate a permanent breast implant. This method eliminates the need for percutaneous saline injections, shortens tissue expansion time from months to weeks, reduces pain and discomfort experienced by patients, can improve cosmetic outcomes for a natural form and shape and reduces overall time and costs. Jeffrey A. Ascherman, MD, FACS, Site Chief, Division of Plastic Surgery at New York-Presbyterian Hospital/Columbia UniversityMedical Center, presented the latest results on 138 patients from the XPAND trial, where 138 patients implanted with the investigational AeroForm successfully completed their expansion within an average of 18.2 days, which is a significant improvement when compared with the 57.4 days of the control group undergoing traditional saline injections. "AeroForm expanders continue to allow women to safely and almost painlessly complete the tissue expansion
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.